| LIFE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LIFE shares outstanding history going back to 5/7/2015:
Also see: LIFE Market Cap History LIFE YTD Return |
LIFE Shares Outstanding History — aTyr Pharma Share Count Over Time
As of 4/30/2024 aTyr Pharma has 69.01 million LIFE shares outstanding. Investors often track the LIFE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LIFE share count trends over time, with 39 historical shares outstanding datapoints presented, dating back to 5/7/2015.
| LIFE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LIFE Historical Shares Outstanding: +51.90% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LIFE Stock Price Chart |
| About aTyr Pharma Inc |
| aTyr Pharma is a biotherapeutics company engaged in the discovery and development of medicines based on biological pathways. Co.'s primary therapeutic candidate efzofitimod, which is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable region of a human antibody. In parallel with Co.'s clinical development of efzofitimod, Co. has been improving its discovery pipeline of NRP2 antibodies and tRNA synthetases. Co.'s investigational new drug candidate ATYR2810, which is a humanized monoclonal antibody that blocks the interaction between NRP2 and one of its primary ligands, vascular endothelial growth factor. We show 39 historical shares outstanding datapoints in our coverage of LIFE's shares outstanding history. Understanding the changing numbers of LIFE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LIFE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LIFE by allowing them to research LIFE shares outstanding history as well as any other stock in our coverage universe. |
| LIFE Current Stock Quote |
Quotes delayed 20 minutes  Free LIFE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| LIFE Share Performance |
| Shares Outstanding Peers |
| aTyr Pharma (LIFE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LIPO Shares Outstanding History LITS Shares Outstanding History LIXT Shares Outstanding History LJPC Shares Outstanding History LLY Shares Outstanding History LMAT Shares Outstanding History LMNX Shares Outstanding History LNSR Shares Outstanding History LNTH Shares Outstanding History LONA Shares Outstanding History More Healthcare companies » |
LIFE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
